June 15th 2025
Explore the top headlines of the week including insights on the latest clinical trials, therapeutic updates, and more.
June 14th 2025
In case you missed it, this week we had news about abrocitinib's flexible dosing for atopic dermatitis, plant-derived exosomes in regenerative skin care, psychosocial support in hidradenitis suppurativa care, and more.
This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.
Catch up on dermatology news, highlights, and insights from the past 24 hours.
June 13th 2025
Daily Derm Times: April 16, 2025
Journal Digest: April 16
This review of the latest dermatologic studies includes insights into dermatologic associations in patients with Crohn disease, the prevalence of tinea pedis in pediatric populations, and more.
Daily Derm Times: April 15, 2025
Evommune Advances EVO756 Into Global Phase 2b Trial for Chronic Spontaneous Urticaria
Evommune has initiated a global phase 2b trial of EVO756, a first-in-class MRGPRX2 antagonist, for moderate to severe CSU.
Nail-Picking and Biting: More Than Bad Habits
In a large study, nearly half of SIND patients also had other BFRBs like skin picking or hair pulling.
Daily Derm Times: April 14, 2025
HyBryte Achieves 75% Treatment Success by Week 18 in Ongoing CTCL Trial
Interim FDA-funded study results show HyBryte delivers rapid, sustained response and strong safety in early-stage CTCL patients.
Top 5 Articles of the Week: April 6-11
Explore the top headlines of the week including insights on infection risks, drug updates, and more.
Dermatology Times' Sunday Crossword: April 13, 2025
Test your knowledge of key words and terms associated with dermatology news from the previous week.
The Weekly Roundup: April 7-11
In case you missed it, this week we had news about Alphyn Biologics' first patient dosed with zabalafin hydrogel, abrocitinib for Netherton Syndrome, the ICONIC-LEAD phase 3 study, and more.
The Rx Recap: April 6-12
This week, we feature top articles from our sister publications on FDA approvals, innovative tech updates, and more.
Daily Derm Times: April 11, 2025
New Qtorin Rapamycin Data Featured at World Congress of Pediatric Dermatology
The presentation, led by Amy Paller, MS, MD, highlighted the upcoming phase 3 SELVA study for microcystic lymphatic malformations.
Daily Derm Times: April 10, 2025
POLL: Which Cosmeceuticals Are Most Popular, According to Social Media?
Google search trends and TikTok view counts were used to analyze the public popularity of cosmeceutical ingredients like retinol, hyaluronic acid, and niacinamide.
ILDS Strengthens Global Commitment to Skin Health Through WHO Partnership Renewal and Call to Action on Corticosteroid Misuse
Henry Lim, MD, discusses the ILDS’ renewed WHO relations status and the global crisis of corticosteroid misuse in skin-bleaching products.
Daily Derm Times: April 9, 2025
Epidemiological Study on Palmoplantar Pustulosis in Korea Highlights Disease Burden and Treatment Gaps
The study revealed high disease burden, poor quality of life, and need for more effective, targeted treatments.
Test Could Help Identify Patients at Risk for Severe Scleroderma
Researchers identify a blood biomarker linked to worse outcomes in diffuse cutaneous systemic sclerosis, paving the way for early detection and treatment.
Journal Digest: April 9
This review of the latest dermatologic studies includes insights into disparities in pediatric atopic dermatitis, nurse-led models for skin cancer detection, and more.
Daily Derm Times: April 8, 2025
Kesty Redness Scale Enhances Analysis of Facial Erythema, Study Reports
The Kesty Redness Scale offers a validated, easy-to-use tool to reliably assess facial redness in clinical dermatology.
Dupilumab Shows No APO Risk During Pregnancy
Compared to untreated patients, dupilumab-treated women showed no increased risk for spontaneous abortion, gestational diabetes, or hypertensive disorders.
Deep Learning Tool Differentiates Keloids From Malignant Lesions Without Dermoscopy
After fine-tuning, the VGG16 convolutional neural network outperformed other deep learning models in 2 of 3 key classification tasks.
Championing Patient and Consumer Safety in Dermatology
Dermatology Times' Editor in Chief Christopher Bunick, MD, PhD, discusses patient safety in the wake of AAD 2025, focusing on BPO recalls, corticosteroid risks, and JAK inhibitor innovations.
Daily Derm Times: April 7, 2025
Allergic Contact Dermatitis Remains Prevalent, Negatively Impacts Quality of Life
Researchers conducted a comprehensive review of ACD, detailing the condition’s epidemiology, pathophysiology, clinical manifestations, diagnostic approaches, and therapeutic options.
Bridging Medicine and Machine Learning
The guide prepares students to critically engage with AI tools and understand their real-world implications.
Large-Spot, Variable-Pulsed KTP Laser Demonstrates Safety and Efficacy in Port-Wine Birthmarks
Long-pulsed KTP laser showed promise as a safe, effective alternative to PDL for treating port-wine birthmarks over 3 years.
Shaping the Future of Dermatology With Insights From AAD 2025 and Beyond
Explore key takeaways from AAD 2025, rosacea insights, psoriasis updates, and expert interviews in the latest issue of Dermatology Times.